Schönthal AH - Search Results

1

Antitumor properties of dimethyl-celecoxib, a derivative of celecoxib that does not inhibit cyclooxygenase-2: implications for glioma therapy.

Schönthal AH. Schönthal AH. Neurosurg Focus. 2006 Apr 15;20(4):E21. doi: 10.3171/foc.2006.20.4.14. Neurosurg Focus. 2006. PMID: 16709027 Review.

2

Induction of p21 mediated by reactive oxygen species formed during the metabolism of aziridinylbenzoquinones by HCT116 cells.

Qiu X, Forman HJ, Schönthal AH, Cadenas E. Qiu X, et al. Among authors: schonthal ah. J Biol Chem. 1996 Dec 13;271(50):31915-21. doi: 10.1074/jbc.271.50.31915. J Biol Chem. 1996. PMID: 8943236

3

Role of p53 in aziridinylbenzoquinone-induced p21waf1 expression.

Wu RC, Hohenstein A, Park JM, Qiu X, Mueller S, Cadenas E, Schönthal AH. Wu RC, et al. Among authors: schonthal ah. Oncogene. 1998 Jul 23;17(3):357-65. doi: 10.1038/sj.onc.1201930. Oncogene. 1998. PMID: 9690517

4

Transcriptional activation of p21WAF1 by PTEN/MMAC1 tumor suppressor.

Wu RC, Li X, Schönthal AH. Wu RC, et al. Among authors: schonthal ah. Mol Cell Biochem. 2000 Jan;203(1-2):59-71. doi: 10.1023/a:1007024624967. Mol Cell Biochem. 2000. PMID: 10724333

5

Role of serine/threonine protein phosphatase 2A in cancer.

Schönthal AH. Schönthal AH. Cancer Lett. 2001 Sep 10;170(1):1-13. doi: 10.1016/s0304-3835(01)00561-4. Cancer Lett. 2001. PMID: 11448528 Review.

6

The type IV phosphodiesterase inhibitor rolipram induces expression of the cell cycle inhibitors p21(Cip1) and p27(Kip1), resulting in growth inhibition, increased differentiation, and subsequent apoptosis of malignant A-172 glioma cells.

Chen TC, Wadsten P, Su S, Rawlinson N, Hofman FM, Hill CK, Schönthal AH. Chen TC, et al. Among authors: schonthal ah. Cancer Biol Ther. 2002 May-Jun;1(3):268-76. doi: 10.4161/cbt.80. Cancer Biol Ther. 2002. PMID: 12432276

7

Suppression of the transformed phenotype and induction of differentiation-like characteristics in cultured ovarian tumor cells by chronic treatment with progesterone.

Blumenthal M, Kardosh A, Dubeau L, Borok Z, Schönthal AH. Blumenthal M, et al. Among authors: schonthal ah. Mol Carcinog. 2003 Dec;38(4):160-9. doi: 10.1002/mc.10155. Mol Carcinog. 2003. PMID: 14639655

8

Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell lines.

Kardosh A, Blumenthal M, Wang WJ, Chen TC, Schönthal AH. Kardosh A, et al. Among authors: schonthal ah. Cancer Biol Ther. 2004 Jan;3(1):55-62. doi: 10.4161/cbt.3.1.571. Epub 2004 Jan 22. Cancer Biol Ther. 2004. PMID: 14726653

9

Inhibition of tumor cell growth by Triton X-100 through specific effects on cell-cycle-regulatory components.

Picache ER, Hassanieh L, Broek D, Schönthal AH. Picache ER, et al. Among authors: schonthal ah. J Biomed Sci. 2004 Jan-Feb;11(1):95-103. doi: 10.1007/BF02256552. J Biomed Sci. 2004. PMID: 14730213

10

Dimethyl-celecoxib (DMC), a derivative of celecoxib that lacks cyclooxygenase-2-inhibitory function, potently mimics the anti-tumor effects of celecoxib on Burkitt's lymphoma in vitro and in vivo.

Kardosh A, Wang W, Uddin J, Petasis NA, Hofman FM, Chen TC, Schönthal AH. Kardosh A, et al. Among authors: schonthal ah. Cancer Biol Ther. 2005 May;4(5):571-82. doi: 10.4161/cbt.4.5.1699. Epub 2005 May 5. Cancer Biol Ther. 2005. PMID: 15846081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results